Peptidyl-arginine modification

pathway activity — cross-omics
GO:0018195Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-arginine modification pathway is significantly associated with the RNA expression of multiple genes, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ZNF728, LINC00702, and RNU6-786P, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-arginine modification activity versus ZNF728 in OV (Pearson r = 0.28).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVZNF728 →-0.911-0.130.009.00933
PDACLINC00702 →-0.266-0.067.006.00533
PDACRNU6-786P →-0.376-0.105.002.00133
HNSCRNA5SP110 →+0.396+0.113.002<.00133
HNSCLINC01003 →+0.313+0.065.008.00233
UCECGPT2 →+0.690+0.131<.001.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018195 vs ZNF728 — OV

Per-sample scatter of Peptidyl-arginine modification activity vs ZNF728 in OV.

Explore this scatter interactively →

Exploration